{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:10:26Z","timestamp":1777011026437,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ab.2012.08.005","type":"journal-article","created":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T10:00:44Z","timestamp":1345543244000},"page":"141-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein"],"prefix":"10.1016","volume":"430","author":[{"given":"Q.","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Garcia-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Manzanarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Silberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Breece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"To","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Thorner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Tomic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2012.08.005_b0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3229","article-title":"Development trends for human monoclonal antibody therapeutics","volume":"9","author":"Nelson","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ab.2012.08.005_b0010","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tibtech.2007.07.005","article-title":"Antibody cocktails: next-generation biopharmaceuticals with improved potency","volume":"25","author":"Logtenberg","year":"2007","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ab.2012.08.005_b0015","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ab.2012.08.005_b0020","doi-asserted-by":"crossref","first-page":"e5672","DOI":"10.1371\/journal.pone.0005672","article-title":"Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants","volume":"4","author":"Prabakaran","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ab.2012.08.005_b0025","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1128\/IAI.00200-09","article-title":"Novel chimpanzee\/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody","volume":"77","author":"Chen","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ab.2012.08.005_b0030","series-title":"The Challenge of Highly Pathogenic Microorganisms","first-page":"275","article-title":"Combination of anthrax\u2013toxin neutralizing antibodies: analysis of synergism\/antagonism effect","author":"Mazor","year":"2010"},{"key":"10.1016\/j.ab.2012.08.005_b0035","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1158\/0008-5472.CAN-09-1417","article-title":"Sym004: a novel synergistic anti-epidermal growth factor receptor antibody mixture with superior anticancer efficacy","volume":"70","author":"Pedersen","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ab.2012.08.005_b0040","unstructured":"European Commission, Production and quality control of monoclonal antibodies, directive 75\/318\/EEC3AB4a, Committee for Medicinal Products for Human Use, 1995."},{"key":"10.1016\/j.ab.2012.08.005_b0045","unstructured":"US Department of Health and Human Services, Points to consider in the manufacture and testing of monoclonal antibody products for human use, Food and Drug Administration, Center for Biologics Evaluation and Research, 1997."},{"key":"10.1016\/j.ab.2012.08.005_b0050","first-page":"42","article-title":"CMC strategy forum report: analysis and structure characterization of monoclonal antibodies","volume":"2","author":"Schenerman","year":"2004","journal-title":"BioProcess Int."},{"key":"10.1016\/j.ab.2012.08.005_b0055","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ab.2012.08.005_b0060","first-page":"275","article-title":"Bioterrorism in Canada: an economic assessment of prevention and postattack response","volume":"12","author":"St. John","year":"2001","journal-title":"Can. J. Infect. Dis."},{"key":"10.1016\/j.ab.2012.08.005_b0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(80)90469-6","article-title":"Hypersensitivity reactions associated with botulinal antitoxin","volume":"69","author":"Black","year":"1980","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ab.2012.08.005_b0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/clinids\/23.2.337","article-title":"Experience with the use of an investigational F(ab\u2032)2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt","volume":"23","author":"Hibbs","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ab.2012.08.005_b0075","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"Nowakowski","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ab.2012.08.005_b0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jim.2007.06.011","article-title":"Evaluation of a peptide ELISA for the detection of rituximab in serum","volume":"325","author":"Blasco","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ab.2012.08.005_b0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ab.2009.05.030","article-title":"Development and validation of an enzyme-linked immunosorbent assay for the quantification of trastuzumab in human serum and plasma","volume":"391","author":"Damen","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2012.08.005_b0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jim.2007.08.008","article-title":"Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays","volume":"328","author":"Tornetta","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ab.2012.08.005_b0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ab.2011.09.030","article-title":"Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein","volume":"421","author":"Meng","year":"2012","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2012.08.005_b0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pep.2005.09.024","article-title":"Expression, purification, and characterization of Clostridium botulinum type B light chain","volume":"46","author":"Gilsdorf","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ab.2012.08.005_b0105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jmb.2006.09.084","article-title":"Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display","volume":"365","author":"Levy","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ab.2012.08.005_b0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/abio.1999.4176","article-title":"Automated kinetic exclusion assays to quantify protein binding interactions in homogeneous solution","volume":"272","author":"Blake","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2012.08.005_b0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/protein\/gzq001","article-title":"Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating","volume":"23","author":"Lou","year":"2010","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ab.2012.08.005_b0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jmb.2005.06.003","article-title":"Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A","volume":"351","author":"Razai","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ab.2012.08.005_b0125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0003-2697(84)90773-5","article-title":"Colorimetric assay for monoamine oxidase in tissues using peroxidase and 2,2\u2019-azinodi(3-ethylbenzthiazoline-6-sulfonic acid) as chromogen","volume":"138","author":"Szutowicz","year":"1984","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ab.2012.08.005_b0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0076-6879(80)70067-8","article-title":"Enzyme immunoassay ELISA and EMIT","volume":"70","author":"Engvall","year":"1980","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ab.2012.08.005_b0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0022-1759(83)90269-7","article-title":"Assessment of substrates for horseradish peroxidase in enzyme immunoassay","volume":"58","author":"Al-Kaissi","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ab.2012.08.005_b0140","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1021\/bi035844k","article-title":"Role of metals in the biological activity of Clostridium botulinum neurotoxins","volume":"43","author":"Eswaramoorthy","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2012.08.005_b0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jmb.2008.12.027","article-title":"Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation","volume":"386","author":"Kumaran","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ab.2012.08.005_b0150","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.4049\/jimmunol.179.5.2815","article-title":"Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen","volume":"179","author":"Tang","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ab.2012.08.005_b0155","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat. Struct. Biol."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269712004034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269712004034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:06:49Z","timestamp":1757711209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269712004034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0003269712004034"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2012.08.005","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2012.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}